Inventor
FALK EUGEN
DE31 patents
⚠️ This page may combine multiple inventors who share the name “FALK EUGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS DEUTSCHLAND
12 patentsUS7335671B2Feb 26, 2008
Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND9 citations83
US7160911B2Jan 9, 2007
Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND14 citations83
US7148246B2Dec 12, 2006
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND18 citations83
US7399777B2Jul 15, 2008
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals
SANOFI AVENTIS DEUTSCHLAND5 citations63
US7259177B2Aug 21, 2007
Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND3 citations62
US7601863B2Oct 13, 2009
Use of PPAR agonists for the treatment of congestive heart failure
SANOFI AVENTIS DEUTSCHLAND0 citations52
US7872034B2Jan 18, 2011
Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7365084B2Apr 29, 2008
Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7956077B2Jun 7, 2011
2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
SANOFI AVENTIS DEUTSCHLAND0 citations50
US7220876B2May 22, 2007
Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND0 citations41
US7598281B2Oct 6, 2009
Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
SANOFI AVENTIS DEUTSCHLAND0 citations39
US7538131B2May 26, 2009
2-{-3-′2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
SANOFI AVENTIS DEUTSCHLAND0 citations39
AVENTIS PHARMA GMBH
10 patentsUS6342512B1Jan 29, 2002
Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH140 citations99
US6624185B2Sep 23, 2003
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH77 citations98
US6884812B2Apr 26, 2005
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH59 citations96
US6451781B1Sep 17, 2002
Substituted acylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
AVENTIS PHARMA GMBH16 citations84
US6632838B1Oct 14, 2003
Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia
AVENTIS PHARMA GMBH16 citations83
US6552048B2Apr 22, 2003
Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH9 citations74
US6339077B1Jan 15, 2002
Substituted 4-benzylaminoquinolines and their hetero analogs, process for their preparation, pharmaceuticals containing these compounds and use thereof
AVENTIS PHARMA GMBH8 citations74
US6596728B1Jul 22, 2003
Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use
AVENTIS PHARMA GMBH2 citations63
US6180618B1Jan 30, 2001
Propanolamine derivatives linked to bile acids, processes for their preparation, pharmaceuticals comprising these compounds, and their use
AVENTIS PHARMA GMBH2 citations63
US8048901B2Nov 1, 2011
1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals
AVENTIS PHARMA GMBH0 citations41
KEIL STEFANIE
3 patentsUS8173674B2May 8, 2012
Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals
KEIL STEFANIE25 citations91
US8946212B2Feb 3, 2015
Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
KEIL STEFANIE0 citations51
US8329725B2Dec 11, 2012
Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
KEIL STEFANIE0 citations48
SANOFI AVENTIS
3 patentsUS7732471B2Jun 8, 2010
6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator—activated receptor (PPAR) ligands, process for their preparation and methods of use thereof
SANOFI AVENTIS0 citations52
US7910612B2Mar 22, 2011
4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use
SANOFI AVENTIS0 citations41
US7858647B2Dec 28, 2010
N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use
SANOFI AVENTIS0 citations41